OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 76 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,699,679 | +31.5% | 2,242,889 | -3.9% | 0.00% | 0.0% |
| Q2 2023 | $21,069,699 | +509.5% | 2,333,300 | +134.2% | 0.00% | – |
| Q1 2023 | $3,456,734 | +35.2% | 996,177 | -4.5% | 0.00% | – |
| Q4 2022 | $2,555,827 | -28.9% | 1,043,195 | -19.9% | 0.00% | – |
| Q3 2022 | $3,593,000 | -32.4% | 1,301,926 | -0.3% | 0.00% | – |
| Q2 2022 | $5,313,000 | -51.1% | 1,305,504 | -48.9% | 0.00% | – |
| Q1 2022 | $10,874,000 | -49.5% | 2,552,949 | +11.1% | 0.00% | -100.0% |
| Q4 2021 | $21,512,000 | -66.6% | 2,298,164 | -1.8% | 0.00% | -50.0% |
| Q3 2021 | $64,490,000 | +56.9% | 2,339,975 | +59.3% | 0.00% | +100.0% |
| Q2 2021 | $41,108,000 | -14.7% | 1,469,179 | +1.1% | 0.00% | 0.0% |
| Q1 2021 | $48,211,000 | +46.4% | 1,453,020 | +112.2% | 0.00% | 0.0% |
| Q4 2020 | $32,921,000 | – | 684,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |